Joint Biology Consortium Resource-based Center
联合生物学联盟资源中心
基本信息
- 批准号:9753918
- 负责人:
- 金额:$ 87.6万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-08-11 至 2021-07-31
- 项目状态:已结题
- 来源:
- 关键词:AdultAmericanAntibodiesArthritisAwardBasophilsBioinformaticsBiologyBloodBostonCRISPR/Cas technologyCell modelCellsChildChildhoodClinicCollaborationsCollectionCommunicationCommunitiesComputerized Medical RecordConsentCountryDataData AnalysesDendritic CellsDevelopmentEnsureEnvironmentFosteringGenerationsGenotypeGrantHealthHealthcareHeartHospitalsHumanImmunologyIn VitroIndividualInflammatory ArthritisInfrastructureInstitutesInstitutionJointsLeadLeadershipLeukocytesLogisticsMedical GeneticsMentorsMethodologyModelingMusOnline SystemsOsteoclastsPatientsPediatric HospitalsPositioning AttributePre-Clinical ModelProgram EvaluationRare Earth MetalsResearchResearch PersonnelResourcesReview CommitteeRheumatologySamplingSeasonsServicesSorting - Cell MovementSpecimenStreamSystemTechniquesTechnologyTimeTissuesTranslational ResearchVisitWomanWorkanalytical toolbasebiobankcohortcollegedata managementdesigndroplet sequencingeosinophilin vivoinnovationinterestmast cellmeetingsmembermonocyteneutrophilnext generationnovelnovel strategiesoperationpatient populationpreclinical studyprofessorprogramsprotocol developmentrecruitservice deliverysingle-cell RNA sequencingsuccesssynergismtooltranscriptome sequencingtranslational scientistweb portal
项目摘要
PROJECT SUMMARY/ABSTRACT - Overall
Breaking down barriers to translational research is the key to finding new approaches to inflammatory arthritis
in adults and children. We therefore propose the Joint Biology Consortium (JBC), a shared infrastructure
based at the Brigham and Women's Hospital, Boston Children's Hospital, and the Broad Institute to accelerate
the work of an arthritis-focused Research Community at 17 research centers in the US and abroad. Three
Cores designed around the shared needs of JBC members will enhance the efficiency of existing studies,
facilitate innovation, and foster junior investigators.
1. The Administrative Core is the organizational heart of the JBC, coordinating operations and cultivating the
scientific potential of the JBC research network. The JBC Synergy Meeting promotes scientific interchange and
collaboration, while the JBC Web Portal facilitates communication and service delivery. The JBC Enrichment
Program, incorporating innovations from award-winning mentors, supports JBC Young Investigators via grant
aims review, a novel mentoring program, and microgrants to enable utilization of JBC core service.
2. The Human Biosamples Core provides “one stop shopping” for adult and pediatric biospecimens essential to
arthritis research. Web-based searches and targeted in-clinic recruitment will transform multiple distinct
resources at BWH and Children's into a unified pipeline for biospecimens and associated clinical and genetic
data.
3. The Cellular Systems Core provides resource- and expertise-intensive tools for arthritis research. Key
services include centralized human sample processing, CyTOF, single-cell and low-input RNA-seq, and an
innovative HoxB8 technology core for generation and CRISPR/Cas9 manipulation of pre-clinical model cells,
including neutrophils, monocytes, and osteoclasts.
Spearheaded by committed arthritis researchers Director Dr. Peter Nigrovic and Associate Director Dr.
Elizabeth Karlson, the JBC will spur innovation within an inclusive and highly collaborative network of senior
and junior investigators, leading the Joint Biology Consortium to become an engine of translational research in
adult and pediatric arthritis.
项目摘要/摘要 - 总体
打破翻译研究的障碍是寻找新方法的炎症性关节炎的关键
在成人和儿童中。因此,我们提出了共享基础设施的联合生物联盟(JBC)
位于波士顿儿童医院的杨百翰和妇女医院和广大研究所加速
美国和国外17个研究中心以关节炎为重点的研究社区的工作。三
围绕JBC成员的共同需求而设计的核心将提高现有研究的效率,
促进创新,并培养初级调查员。
1。行政核心是JBC的组织心脏,协调操作和培养
JBC研究网络的科学潜力。 JBC协同会议促进了科学互换和
协作,而JBC Web门户网站促进了通信和服务交付。 JBC富集
计划结合了屡获殊荣的导师的创新,通过格兰特支持JBC年轻调查员
Aims Review是一种新颖的心理计划,以及可利用JBC核心服务的微电磁。
2。人类生物样本核心为成人和小儿生物测量提供“一站式购物”
关节炎研究。基于Web的搜索和针对性的临界招聘将改变多个不同的不同
BWH的资源和儿童的生物测量和相关临床和遗传的统一管道
数据。
3。细胞系统核心为关节炎研究提供了资源和专业的密集型工具。钥匙
服务包括集中的人类样品处理,细胞,单细胞和低输入RNA-seq,以及
创新的HOXB8技术核心用于生成和CRISPR/CAS9操纵前临床模型细胞的核心,
包括中性粒细胞,单核细胞和破骨细胞。
由承诺的关节炎研究人员主任Peter Nigrovic博士和副主任博士带头。
伊丽莎白·卡尔森(Elizabeth Karlson),JBC将刺激创新,包括高级高级合作网络
和初级研究人员,领导联合生物学财团成为转化研究的引擎
成人和小儿关节炎。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Peter A Nigrovic其他文献
Peter A Nigrovic的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Peter A Nigrovic', 18)}}的其他基金
Modulation of neutrophil function through emperipolesis
通过伸入调节中性粒细胞功能
- 批准号:
10091401 - 财政年份:2020
- 资助金额:
$ 87.6万 - 项目类别:
Modulation of neutrophil function through emperipolesis
通过伸入调节中性粒细胞功能
- 批准号:
10656013 - 财政年份:2020
- 资助金额:
$ 87.6万 - 项目类别:
Bridging the gap between GWAS and mechanism in JIA
弥合 GWAS 和 JIA 机制之间的差距
- 批准号:
10064581 - 财政年份:2018
- 资助金额:
$ 87.6万 - 项目类别:
Bridging the gap between GWAS and mechanism in JIA
弥合 GWAS 和 JIA 机制之间的差距
- 批准号:
10675585 - 财政年份:2018
- 资助金额:
$ 87.6万 - 项目类别:
Bridging the gap between GWAS and mechanism in JIA
弥合 GWAS 和 JIA 机制之间的差距
- 批准号:
10622118 - 财政年份:2018
- 资助金额:
$ 87.6万 - 项目类别:
相似海外基金
The role of BET proteins in pathological cardiac remodeling
BET蛋白在病理性心脏重塑中的作用
- 批准号:
10538142 - 财政年份:2023
- 资助金额:
$ 87.6万 - 项目类别:
A Potent D-peptide Inhibitor of TNFα for Treatment of Rheumatoid Arthritis
一种有效的 TNFα D 肽抑制剂,用于治疗类风湿性关节炎
- 批准号:
10822182 - 财政年份:2023
- 资助金额:
$ 87.6万 - 项目类别:
Targeting Macrophages to Treat Soft Tissue Sarcomas
靶向巨噬细胞治疗软组织肉瘤
- 批准号:
10760719 - 财政年份:2023
- 资助金额:
$ 87.6万 - 项目类别:
Skeletal Muscle Wasting as a Modifiable Target for Treating Patients with Heart Failure with Reduced Ejection Fraction
骨骼肌萎缩作为治疗射血分数降低的心力衰竭患者的可修改目标
- 批准号:
10567792 - 财政年份:2023
- 资助金额:
$ 87.6万 - 项目类别:
CD98hc Brain Shuttles for Delivering Off-the-shelf Neuroprotective Antibodies in Alzheimer's Disease
CD98hc 脑穿梭机为阿尔茨海默病提供现成的神经保护抗体
- 批准号:
10566062 - 财政年份:2023
- 资助金额:
$ 87.6万 - 项目类别: